52 results on '"Cappelletti, V."'
Search Results
2. 26P ctDNA prognostic and diagnostic value for recurrence in patients with early-stage breast cancer: A systematic review and meta-analysis
3. 51P Clinical and biological significance of low ERBB2 expression in ductal carcinoma in situ (DCIS) of the breast
4. 136P Paths of chromosomal instability and copy number alteration in circulating tumor cells of progressing early-stage breast cancer patients
5. 2MO Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients
6. Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
7. Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
8. 12P The RODILIA pilot study for molecular screening of patients with metaplastic breast cancer
9. Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
10. Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial
11. 59P Primary tumour and circulating tumour cell (CTC) copy number alterations (CNAs) in triple negative breast cancer (TNBC) patients (pts) treated with neoadjuvant chemotherapy (NAC)
12. Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study
13. Use of red clover in premenopausal breast cancer patients receiving hormonal adjuvant treatment: Biological and clinical implications from a randomized clinical trial
14. Subgroups analysis and circulating biomarkers evaluation of RESORT trial: A randomized phase II study in metastatic renal cell carcinoma (mRCC) patients (pts) to evaluate the efficacy of sorafenib after metastasectomy
15. Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells
16. Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC)
17. Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC)
18. It's not the quality but the quantity: tumor mutation spectrum and response to neoadjuvant therapy in triple negative breast cancer
19. Extracellular matrix proteins derived from the tumor microenvironment as circulating breast cancer diagnostic markers
20. miR-30e* is an independent subtype-specific prognostic marker in breast cancer
21. Circulating Biomarkers for Prediction of Treatment Response
22. Rodolfo Virchow e il metodo della terapia
23. Circulating Tumor Cells (CTCS) as Prognostic Biomarker in Patients with Advanced Chemorefractory, Ras Wild-Type Colorectal Cancer (CRC) Treated with Cetuximab or Panitumumab
24. 791 Phase 2 study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676)
25. 784 Quantification and molecular profiling of circulating tumour cells (CTCs) in urothelial cancer (UC) before and during systemic treatment: Implications across the clinical stages
26. 835 Improving the Reliability of Gene Expression Profiles From FFPE Samples Using Alternative Chip Description Files
27. Strategies to Translate Preclinical Information to Breast Cancer Patient Benefit
28. PP 83 Gene expression profiling of circulating tumor cells in breast cancer
29. PP 77 Dissecting time- from tumor-related gene expression variability in the bilateral breast cancer model
30. PP110 Effect of fixative and sample age on success rate in gene profiling studies
31. PP108 Genes associated to development of distant metastases in node negative breast cancer patients
32. PP109 Comparability and reliability of different approaches to obtain gene expression measurements from formalin-fixed, paraffin-embedded breast cancer samples
33. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
34. Questioning the Utility of Pooling Samples in Microarray Experiments with Cell Lines
35. Questioning the utility of pooling samples in microarray experiments with cell lines
36. Efficacy of neoadjuvant toremifene (TOR) and intratumor expression of estrogen receptor (ER) Α and Β in elderly breast cancer (BC) patients
37. Efficacy of neoadjuvant toremifene (TOR) and intratumor expression of estrogen receptor (ER) Α and Β in elderly breast cancer (BC) patients
38. Re: Tamoxifen May Be an Effective Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status
39. Selective modulation of ER-? by estradiol and xenoestrogens in human breast cancer cell lines
40. Genistein blocks breast cancer cells in the G2M phase of the cell cycle
41. Genistein blocks breast cancer cells in the G2M phase of the cell cycle
42. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
43. Modulation of Cathepsin-D and pS2 Protein Levels in Human Breast Cancer Cell Lines
44. p53 as an Independent Prognostic Marker in Lymph Node-Negative Breast Cancer Patients
45. Interaction between hormone-dependent and hormone-independent human breast cancer cells
46. Activity of Tamoxifen and Its Metabolites on Endocrine-Dependent and Endocrine-Independent Breast Cancer Cells
47. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells
48. Relationship between ER-ICA and conventional steroid receptor assays in human breast cancer
49. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques
50. Il Rene Escluso: Considerazioni Arteriografiche
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.